[Form 4] APOGEE ENTERPRISES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Apogee Enterprises director Donald A. Nolan received deferred equity awards on 09/30/2025: 62 phantom stock units and 179 deferred restricted stock units. Each unit is settled 1‑for‑1 into common stock and is shown at a per‑share value of $43.57. After these allocations, the reporting table lists 10,453 phantom stock units and 30,195 deferred restricted stock units beneficially owned by Mr. Nolan in direct form. The phantom units were granted under the Deferred Compensation Plan for Non‑Employee Directors and the deferred restricted stock units under the 2009 and 2019 Non‑Employee Director Stock Plans; both will convert to common shares upon events specified in those plans, such as the director’s termination from the board.

Positive

• 62 phantom stock units and 179 deferred restricted stock units were allocated, showing continued director alignment with shareholders
• Awards settle 1‑for‑1 into common shares, providing straightforward share conversion
• Dividend equivalent reinvestment increased unit counts, preserving value of deferred awards

Negative

• None.

Insights

Corporate Governance Analyst

Director received deferred equity grants that convert 1:1 to common shares.

These awards are standard non‑employee director compensation: 62 phantom units and 179 deferred restricted stock units were added on 09/30/2025. Both award types state 1‑for‑1 settlement into common stock and are governed by the board plans cited.

The grants include dividend reinvestment increments and remain in direct beneficial form totaling 10,453 and 30,195 units respectively; they will settle into shares upon plan‑specified events.

Compensation Specialist

Awards reflect routine director deferred compensation mechanics, not option exercises.

The phantom stock units and deferred restricted stock units are equity‑linked deferred awards rather than exercised options, and the record shows a unit valuation of $43.57. The allocation method includes a dividend equivalent reinvestment feature that increased the unit counts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Nolan Donald A

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	(2)	09/30/2025		A(3)		62		(1)	(1)	Common Stock	62	$43.57	10,453	D
Deferred Restricted Stock Units(4)	(2)	09/30/2025		A(5)		179		(4)	(4)	Common Stock	179	$43.57	30,195	D

Explanation of Responses:

1. The phantom stock units were allocated under the Deferred Compensation Plan for Non-Employee Directors. The phantom stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

2. Settled 1-for-1.

3. Additional phantom stock units acquired pursuant to a dividend equivalent reinvestment feature of the Deferred Compensation Plan for Non-Employee Directors.

4. The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

5. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/ Meghan M. Elliott, Attorney-in-Fact for Donald A. Nolan	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity did APOG director Donald A. Nolan receive on 09/30/2025?

He was allocated 62 phantom stock units and 179 deferred restricted stock units, each settled 1‑for‑1 into common stock.

Under which plans were the units granted to Donald A. Nolan?

Phantom units were granted under the Deferred Compensation Plan for Non‑Employee Directors; deferred restricted stock units were granted under the 2009 Non‑Employee Director Stock Incentive Plan and the 2019 Non‑Employee Director Stock Plan.

How many units does Donald A. Nolan beneficially own following these transactions?

The Form 4 lists 10,453 phantom stock units and 30,195 deferred restricted stock units beneficially owned in direct form.

What is the per‑share value shown for the reported units?

The units are shown at a per‑share value of $43.57 in the filing.

Will the phantom and deferred restricted units convert into APOG common stock?

Yes. The filing states both award types will be settled in shares of common stock upon the director’s termination from the board or other plan‑specified events.